National Bank of Canada
PRAX icon

National Bank of Canada’s Praxis Precision Medicines PRAX Stock Holding History

National Bank of Canada’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$641 Buy
+2
New +$619 ﹤0.01% 2722
2025
Q3 		– Sell
-1
Closed -$42 – 3143
2025
Q2 		$42 Buy
+1
New +$38 ﹤0.01% 2911
2024
Q4 		– Sell
-1
Closed -$58 – 3154
2024
Q3 		$58 Buy
+1
New +$54 ﹤0.01% 2586

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

National Bank of Canada's PRAX Position: Q1 2026 in Review

National Bank of Canada opened a new position in Praxis Precision Medicines (PRAX) in Q1 2026: 2 shares worth $641. The stake represents ﹤0.01% of the portfolio and ranks #2722 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in PRAX as recently as Q2 2025.

National Bank of Canada first reported a position in PRAX in Q3 2024 and has held it in 3 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • National Bank of Canada held 2 shares of Praxis Precision Medicines worth $641 as of Q1 2026.
  • Praxis Precision Medicines was a new National Bank of Canada position in Q1 2026.
  • Praxis Precision Medicines made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2722 holding.
  • National Bank of Canada first reported a position in Praxis Precision Medicines in Q3 2024 and has held it in 3 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.